Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
Sheharyar Raza, Transfusion Medicine Specialist at Sunnybrook Health Sciences Center and Internal Medicine Physician at Unity Health Toronto, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Multiple Sclerosis and Related Disorders, adding:
”Plasma Exchange is a life-saving therapy that replaces patient plasma with donor plasma or derivatives.
While reasons to transfuse plasma are generally shrinking for many indications (because we now produce more specialised products for most diseases), PLasma EXchange (PLEX) is growing and remains indispensable. Many patients requiring PLEX will need large volumes of plasma or derivatives over multiple sessions administered by highly specialized nurses, and can develop serious disability or die without it. Despite being medically necessary, PLEX is only accessible at a select few, large centers in most countries, leading to delayed or non-treatment.
We performed an analysis of 52000 patients with Multiple Sclerosis captured in ICES and found that PLEX use has increased 3-fold over the last 3 decades, with a potential signal that it may be less available to patients presenting to rural hospitals.
Access publication lead by Manav Vyas, Katerina, et al.”
Title: Therapeutic Plasma Exchange in People with Multiple Sclerosis: A Province-Wide Study
Authors: Manav V. Vyas, Sheharyar Raza, Karl Everett, Tomi Odugbemi, Amirah Momen, Foad Taghdiri, Jiming Fang, Dalia Rotstein, Jiwon Oh, Katerina Pavenski
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke
-
Sep 14, 2026, 23:42Eman M. Elsabbagh: Successful HCT Does Not End at Engraftment
-
Sep 14, 2026, 23:31Antonis Kattamis: Proud to Be Part of this Endeavour and Senior Author of the Pivotal Trial
-
Sep 14, 2026, 23:23Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease
-
Sep 14, 2026, 20:53YoonHwa An: Rusfertide in Polycythemia Vera – From Clinical Benefit to Strategic Value
-
Sep 14, 2026, 20:52Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
-
Sep 14, 2026, 20:50Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation
-
Sep 14, 2026, 20:48Valerie Dehondt: Nutritional Anemia Is Associated With Increased Risk of Severe COPD Exacerbations
-
Sep 14, 2026, 20:46Nupur Choudhury: Exploring AI-Based Detection of Anemia Using Eye and Fingernail Images